INTANGIBLE ASSETS (Tables)

12 Months Ended

Dec. 31, 2012

Intangible assets are comprised of patents acquired in October, 2005. Intangible assets, net consisted of the following at December 31:

Intangible assets	2012			2011
Patent - Amlexanox (Aphthasol®)	$	2,090,000		$	2,090,000
Patent - Amlexanox (OraDisc™ A)		6,873,080			6,873,080
Patent - OraDisc™		73,000			73,000
Patent - Hydrogel nanoparticle aggregate		589,858			589,858
		9,625,938			9,625,938
Less: accumulated amortization		(5,479,953	)		(5,003,503	)
Intangible assets, net	$	4,145,985		$	4,622,435

Future aggregate amortization expense for intangible assets

Amortization expense for intangible assets was $476,450 and $769,132 for the years ended December 31, 2012 and 2011, respectively. The future aggregate amortization expense for intangible assets, remaining as of December 31, 2012, is as follows:

Calendar Years	Future Amortization Expense
2013	$	475,148
2014		475,148
2015		475,148
2016		476,450
2017		475,148
2018 & Beyond		1,768,943
Total	$	4,145,985